Abstract
Human Gene TherapyVol. 25, No. 1 BriefsGene Therapy BriefsAlex PhilippidisAlex PhilippidisSearch for more papers by this authorPublished Online:20 Jan 2014https://doi.org/10.1089/hum.2013.2526AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byPhase I/II Gene Therapy Trial of Fanconi Anemia Patients with a New Orphan Drug Consisting of a Lentiviral Vector Carrying the FANCA Gene: A Coordinated International Action (EuroFancolen)18 June 2015 | Human Gene Therapy Clinical Development, Vol. 26, No. 2Does Vascular Endothelial Growth Factor Gene Therapy Safely Improve Outcome in Severe Early-Onset Fetal Growth Restriction? (EVERREST)18 June 2015 | Human Gene Therapy Clinical Development, Vol. 26, No. 2 Volume 25Issue 1Jan 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Alex Philippidis.Gene Therapy Briefs.Human Gene Therapy.Jan 2014.12-16.http://doi.org/10.1089/hum.2013.2526Published in Volume: 25 Issue 1: January 20, 2014PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: Human Gene Therapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
